
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death.
On the Mayo Clinic Q&A podcast, Dr. Michael Ackerman, a Mayo Clinic genetic cardiologist and director of the Windland Smith Rice Sudden Death Genomics Laboratory, explains how heart monitoring is important to identify at-risk patients.
Click the player below:
Mayo Clinic Q&A is available on podcast platforms including Apple, Google, Spotify, Stitcher, TuneIn and iHeart.
_________________________________________________
For the latest updates on the COVID-19 pandemic, check the CDC website. For more information and COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
DEAR MAYO CLINIC: The Food and Drug Administration recently approved two new COVID-19 vaccines from Pfizer and Moderna. What are the recommendations for who should ...
Influenza, COVID-19, the common cold and respiratory syncytial virus (RSV) are among the respiratory viruses that will be circulating this fall and winter seasons. These ...
If you haven't had the flu in a few years, there's a reason. As Dr. Nipunie Rajapakse, a pediatric infectious diseases physician with the Mayo Clinic Children's Center, shares, ...